iTeos Therapeutics, Inc.
ITOS · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $434,339 | $258,151 | $310,843 | $440,413 |
| - Cash | $207,820 | $156,544 | $142,131 | $123,744 |
| + Debt | $5,128 | $5,053 | $5,096 | $5,528 |
| Enterprise Value | $231,647 | $106,660 | $173,808 | $322,197 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$324 | -$34,388 | -$302 |
| % Margin | – | – | – | – |
| EBITDA | -$66,181 | -$33,682 | -$47,777 | -$47,693 |
| % Margin | – | – | – | – |
| Net Income | -$78,729 | -$34,613 | -$43,712 | -$45,358 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.81 | -0.8 | -1.08 | -1.05 |
| % Growth | -126.3% | 25.9% | -2.9% | – |
| Operating Cash Flow | -$42,446 | -$33,764 | $5,497 | -$37,351 |
| Capital Expenditures | -$283 | -$101 | -$152 | -$94 |
| Free Cash Flow | -$42,729 | -$33,865 | $5,345 | -$37,445 |